Co-Chairs: S Tobe, M Lebel |
Central Review Committee: B Hemmelgarn (Chair), D Hackam, M Hill, N Khan, J Mahon, R Padwal, R Quinn |
Subgroups |
Ambulatory Blood Pressure Monitoring: M Myers (Chair), M Dawes |
Lifestyle Modification in Hypertension: R Touyz (Chair), N Campbell, L Trudeau, S Bacon, R Petrella |
Adherence Strategies for Patients: T Campbell (Chair), R Feldman, A Milot, J Stone, D Drouin |
Accurate Measurement of Blood Pressure: L Cloutier (Chair), K Mann, M Lamarre-Cliche |
Cardiovascular Risk Assessment: S Grover (Chair), G Tremblay, A Milot |
Pharmacotherapy for Hypertensive Patients with Cardiovascular Disease: S Rabkin (Chair), M Arnold, G Moe, J Howlett |
Echocardiography: G Honos (Chair) |
Pharmacotherapy for Hypertensive Patients Without Compelling Indications: R Herman (Chair), P Hamet, G Fodor, G Dresser, G Carruthers, G Pylypchuk, E Burgess |
Endocrinological Forms of Hypertension: EL Schiffrin (Chair) |
Renal and Renovascular Hypertension: M Ruzicka (Chair), K Burns, S Tobe, M Vallée, R Prasad, M Lebel |
Follow-up on Patients with Hypertension: P Bolli (Chair), G Tremblay |
Routine Laboratory Tests: T Wilson (Chair), B Penner |
Hypertension & Diabetes: P Larochelle (Chair), R Gilbert, L Leiter, C Jones, R Ogilvie, S Tobe, V Woo |
Self Measurement of Blood Pressure: D McKay (Chair), A Chockalingam, D McLean |
Vascular Protection: R Feldman (Chair), EL Schiffrin, R Hegele, P McFarlane |
Pharmacotherapy for Hypertensive Patients with Cerebrovascular Disease: P Lindsay (Chair), J-M Boulanger, M Sharma |